Testing Choices: From the standard to the extraordinary
Test | Test Name |
---|---|
0500B | Barbital, Blood |
0500SP | Barbital, Serum/Plasma |
0500U | Barbital, Urine |
0512B | Barbiturates Screen, Blood |
0512SP | Barbiturates Screen, Serum/Plasma |
0512U | Barbiturates Screen, Urine |
0585B | Benzonatate, Blood |
0585SP | Benzonatate, Serum/Plasma |
0585U | Benzonatate, Urine |
0810B | Butabarbital, Blood |
0810SP | Butabarbital, Serum/Plasma |
0810U | Butabarbital, Urine |
0830B | Butalbital, Blood |
0830SP | Butalbital, Serum/Plasma |
0830U | Butalbital, Urine |
6921H | Barbiturates Screen, Hair |
8620B | Barbiturates Panel, Blood |
8620FL | Barbiturates Panel, Fluid |
8620ME | Barbiturates Panel (Qualitative), Meconium |
8620SP | Barbiturates Panel, Serum/Plasma |
8620TI | Barbiturates Panel, Tissue |
8620U | Barbiturates Panel, Urine |
9329ME | Benzodiazepines Panel (Qualitative), Meconium |
9351UC | Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |